GLP-1 Therapy Guidance
Physician-guided GLP-1 medicines to lower blood sugar and support weight loss.
GLP-1 therapy in India uses a class of prescription medicines, such as semaglutide and dulaglutide, that lower blood sugar and reduce appetite to support steady weight loss. At EDFC, GLP-1 treatment is always physician-guided, matched to your health and monitored closely for safety.
How do GLP-1 medicines work?
GLP-1 receptor agonists copy a natural gut hormone that tells the body to release insulin after eating, slows stomach emptying and signals fullness to the brain. The result is better blood sugar control and less hunger. The International Diabetes Federation recognises this drug class as an important option in type 2 diabetes, especially when weight is also a concern.
Who is GLP-1 therapy suitable for?
These medicines are prescription only and are considered for adults with type 2 diabetes or obesity related risk, after a full review of your history. They are not for everyone, and our team checks suitability before starting. Common early effects include mild nausea that usually settles. Popular options are covered in our Mounjaro programme and Ozempic and Wegovy programme.
Why choose EDFC for GLP-1 therapy in India?
Our team starts you on the right dose, tracks your response and links treatment to body composition and blood sugar data rather than the number on the scale alone. GLP-1 care sits within our wider advanced diabetes therapies. Book a review with our clinic team. This page is educational and not a substitute for a consultation.